The transcription factor nuclear factor-kappa B (NF-kappa B) regulates gene
s that can influence cell proliferation, apoptosis, and inflammatory respon
ses. Since these events can contribute to carcinogenesis, we examined the e
xpression of NF-kappa B inhibitory proteins (I kappa Bs) in normal and tran
sformed colonic epithelial cells. Immunohistochemical analysis of the mouse
colon revealed a high level of I kappa B beta expression in epithelial cel
ls relative to the rest of the tissue, whereas I kappa B alpha was found pr
imarily in cells of the lamina propria. Mouse colon tumors showed a similar
cell-specific staining pattern. Immunoblot analysis of I kappa B beta from
mouse colonocytes and the human HT-29 colon cancer cell line indicated tha
t most of the I kappa B beta in these cells was similar to the C-terminal-t
runcated I kappa B beta 2 isoform. Cell fractionation studies were consiste
nt with I kappa B beta being a major regulator of p65-p50 NF-kappa B comple
xes in HT-29 cells. Interestingly, two larger proteins specifically recogni
zed by I kappa B beta antibodies (p106 and p112)were found in HT-29 cells a
nd in colon tissue of carcinogen-exposed mice. The p106 and p112 proteins b
ound to NF-kappa B, and their levels changed during the transient interleuk
in-1 beta activation of NF-kappa B in HT-29 cells. Evidence was obtained in
dicating that p106 and p112 are stably ubiquitinated forms of I kappa B bet
a. We propose that deficiencies in the proteasomal degradation of I kappa B
beta lead to p106 and p112 accumulation, which in turn alter NF-kappa B re
gulation in colon cancer cells. Mel. Carcinog. 29:25-36, 2000. (C) 2000 Wil
ey-Liss, Inc.